피플바이오

304840KOSDAQ

54.5 / 100

Reference Date: 2026-10-23

Financial Score22.0 / 40

News Sentiment12.5 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

PeopleBio is a biotech company specializing in the development of biomarker-based diagnostic technologies for early detection of Alzheimer's disease. The company's SI-MDS technology enables the detection of oligomeric beta-amyloid through blood tests, offering a cost-effective and efficient alternative to existing methods like PET or lumbar puncture. With rising demand for dementia diagnostics due to aging populations, the market is expected to grow significantly.

Number of Employees

43people

Average Salary

60.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.48Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-93.48Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

6.75Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼19.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲25.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -106.2% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 561Won52-week high 2,01552-week low 561

1-month return3.0Point

1m 0% (flat)

Volume trend6.0Point

Volume surge

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral[기재정정]주식병합결정2026-10-21
Neutral주식등의대량보유상황보고서(일반)2026-10-08
Neutral주식등의대량보유상황보고서(일반)2026-10-08
Neutral타인에대한담보제공결정2026-09-28